We are live on ! Find out more
ET

Entropy Technologies Portfolio holdings

AUM $2.17B
1-Year Est. Return 21.46%
This Fund
S&P 500
This Quarter Est. Return
-1.33%
1 Year Est. Return
+21.46%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$925M
AUM Growth
-$12.8M
Cap. Flow
+$5.13M
Cap. Flow %
0.55%
Top 10 Hldgs %
10.78%
Holding
990
New
294
Increased
162
Reduced
185
Closed
349

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$10.6M
2
COST icon
Costco
COST
+$9.16M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.13M
4
ELV icon
Elevance Health
ELV
+$8.43M
5
CMS icon
CMS Energy
CMS
+$8.4M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.51M
2
EA icon
Electronic Arts
EA
+$7.49M
3
ZTS icon
Zoetis
ZTS
+$7.45M
4
CB icon
Chubb
CB
+$7.14M
5
MU icon
Micron Technology
MU
+$7.08M

Sector Composition

Rank Sector Weight
1 Technology 17.78%
2 Financials 14.36%
3 Industrials 14.14%
4 Consumer Discretionary 12.23%
5 Healthcare 11.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACDC icon
626
ProFrac Holding
ACDC
$686M
$124K 0.01%
+16,676
New +$138K
BRY
627
DELISTED
Berry Corp
BRY
$120K 0.01%
+18,640
New +$139K
VIR icon
628
Vir Biotechnology
VIR
$1.48B
$112K 0.01%
+12,573
New +$121K
AMCX icon
629
AMC Global Media
AMCX
$448M
$112K 0.01%
+11,581
New +$153K
ARQT icon
630
Arcutis Biotherapeutics
ARQT
$3.54B
$109K 0.01%
+11,772
New +$106K
HAIN icon
631
Hain Celestial
HAIN
$45.5M
$109K 0.01%
+15,708
New +$108K
ACRE
632
Ares Commercial Real Estate
ACRE
$257M
$101K 0.01%
15,191
-6,798
-31% -$47K
HTBK
633
DELISTED
Heritage Commerce
HTBK
$96.9K 0.01%
11,134
-8,500
-43% -$69.2K
AAOI icon
634
Applied Optoelectronics
AAOI
$6.99B
$92.8K 0.01%
+11,196
New +$123K
NAPA
635
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$89.8K 0.01%
+12,649
New +$102K
COGT icon
636
Cogent Biosciences
COGT
$6.81B
$89.7K 0.01%
10,638
-20,994
-66% -$159K
KOS icon
637
Kosmos Energy
KOS
$1.41B
$83.8K 0.01%
+15,133
New +$88.3K
JRVR icon
638
James River Group Holdings
JRVR
$222M
$82.9K 0.01%
10,722
-27,409
-72% -$225K
ADT icon
639
ADT
ADT
$5.34B
$80.2K 0.01%
10,550
-82,200
-89% -$569K
ADAM
640
Adamas Trust
ADAM
$787M
$72.6K 0.01%
+12,427
New +$79.7K
RES icon
641
RPC Inc
RES
$1.16B
$72.2K 0.01%
11,556
-7,534
-39% -$52.7K
AA icon
642
Alcoa
AA
$11.7B
-47,174
Closed -$1.59M
AAON icon
643
Aaon
AAON
$7.74B
-4,805
Closed -$423K
ABR icon
644
Arbor Realty Trust
ABR
$983M
-87,851
Closed -$1.16M
ACA icon
645
Arcosa
ACA
$7.13B
-6,557
Closed -$563K
ACI icon
646
Albertsons Companies
ACI
$5.7B
-30,061
Closed -$645K
ACLX
647
DELISTED
Arcellx
ACLX
-14,526
Closed -$1.01M
ACMR icon
648
ACM Research
ACMR
$5.02B
-22,316
Closed -$650K
ACT icon
649
Enact Holdings
ACT
$6.7B
-7,205
Closed -$225K
ADI icon
650
Analog Devices
ADI
$179B
-26,314
Closed -$5.2M

Similar funds

Entropy Technologies's Q2 2024 Portfolio in Review

As of Q2 2024, Entropy Technologies held 990 positions worth $925M, down 1.4% from $938M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Entropy Technologies's Q2 2024 filing shows 294 new, 162 increased, 185 reduced and 349 closed positions. Its largest new stake was CVS Health: 169,946 shares worth $10M. The largest sale was UnitedHealth, an estimated $7.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

  • Entropy Technologies's largest Q2 2024 buy was CVS Health: 169,946 shares worth $10M.
  • Entropy Technologies added most to Berkshire Hathaway Class B in Q2 2024, an estimated $9.13M increase.
  • Entropy Technologies's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $7.08M.
  • Entropy Technologies fully exited UnitedHealth in Q2 2024, selling an estimated $7.51M.
  • Entropy Technologies's ten largest holdings make up 11% of its $925M portfolio in Q2 2024.
  • Entropy Technologies opened 294 new positions and closed 349 in Q2 2024.
  • Entropy Technologies's portfolio value fell 1.4% quarter-over-quarter to $925M.

Based on Entropy Technologies's 13F filing for Q2 2024, filed 12 Aug 2024.